Reshape Lifesciences Inc (RSLS) Return on Investment ROI from the first quarter of 2026 to first quarter of 2024 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Reshape Lifesciences Inc  (NASDAQ: RSLS)


Reshape Lifesciences Inc's ROI from its first quarter of 2026 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Reshape Lifesciences Inc's ROI in the first quarter of 2026?
Reshape Lifesciences Inc recorded a cumulative net loss of $-10 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -667.21%.

Within the Healthcare sector 702 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2026 quarter, so far to 3622, from total ROI ranking in the third quarter of 2025 at 3695.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 9 5 -5 -4 -4
Return On Investment (TTM) -667.21 % 579.58 % - - -
RSLS's Overall Ranking # 3622 # 3695 # 3400 # 3956 #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -10 -11 -3 -3 -3

RSLS Company Profile >> Back to RSLS Roi Comparisons >> See Annual RSLS Return On Investment



Return On Investment RSLS's Ranking
Within: No.
Industry # 329
Sector # 703
Overall # 3622

Return On Investment Statistics
High Average Low
-68.4 %
-190.19 %
-486.01 %
(Mar 31 2018)   (Mar 31 2017)



  News about Reshape Lifesciences Inc Return on Investment ROI

Reshape Lifesciences: A Promising Rebirth towards Profitability in the Healthcare Market

March 4, 2024


Reshape Lifesciences: A Promising Turnaround in the Making
In a recent announcement, Reshape Lifesciences provided an update on its 2024 cost reduction plan and reorganization strategy, signaling a significant shift towards the commercialization of its Lap-Band 2.0 FLEX. With the aim of prioritizing profitability, the company expects operating expenses to decrease by a staggering 55.4% compared to the previous year.
However, the path leading up to this point has been marred by financial challenges. Reshape Lifesciences recorded a cumulative net loss of $26 million during the 12-month period ending in the third quarter of 2023. This dismal performance resulted in a negative return on investment (ROI) of -453.13%, painting a bleak picture for investors.





Financial Statements
Reshape Lifesciences Inc's I. Quarter Investments $ 9 Millions RSLS's Balance sheet
Reshape Lifesciences Inc's I. Quarter Income $ -1 Millions Quarterly RSLS's Income Statement
RSLS's Income by Division See RSLS's Income by Division


RSLS Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 0 7 4 47 25
Y / Y Investment Growth - 88.09 % -92.2 % 84.35 % -13.02 %
Net Income in Millions -7 -11 -46 -62 -22
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -165.36 % -1262.33 % -131.98 % -84.97 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RSLS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RSLS's Competitors
Subscribers only: Roi for Reshape Lifesciences Inc's Suppliers
Subscribers only: Return On Investment for RSLS's Customers

Other Ratios
RSLS's Roa RSLS's Inventory Turnover Ratio RSLS's Growth Rates RSLS's Dividend Statistics
RSLS's Profitability Ratios RSLS's Asset Turnover Ratio RSLS's Dividend Growth
RSLS's Roe RSLS's Valuation Ratios RSLS's Financial Strength Ratios RSLS's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:30:32+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.